Results 11 to 20 of about 15,339 (211)

Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology. [PDF]

open access: yes, 2014
Maladaptive plasticity can be defined as behavioral loss or even development of disease symptoms resulting from aberrant plasticity changes in the human brain.
Ahmed   +58 more
core   +2 more sources

Tardive dyskinesia

open access: yesConsilium Medicum, 2021
Tardive dyskinesia is a group of hyperkinetic and hypokinetic movement disorders, following the administration of dopamine receptor-blocking drugs. The severity of these syndromes varies from soft forms to the development of life-degrading situations ...
Violetta A. Tolmacheva
doaj   +1 more source

Tardive dyskinesia on clozapine: A case report

open access: yesSouth African Journal of Psychiatry, 2009
Antipsychotic-induced tardive dyskinesia is a potentially irremediable and debilitating condition with the onset most commonly associated with the use of first-generation antipsychotics.
Laila Asmal
doaj   +1 more source

Treatment of tardive dyskinesia caused by long-term antipsychotic use: case reports and literature review

open access: yesNeurologijos seminarai, 2020
Introduction. Tardive dyskinesia is a movement disorder that begins with exposure to dopamine receptor-blocking agents for at least a few months. These agents include most of antipsychotics, which are widely used to treat mental illness.
I. Pabarčiūtė , M. Karnickas
doaj   +1 more source

Fluphenazine decanoate (depot) and enanthate for schizophrenia [PDF]

open access: yes, 2015
Background: Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance.
Abuzzahab   +336 more
core   +1 more source

Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders - A case series [PDF]

open access: yes, 2002
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still ...
Amann, B.   +5 more
core   +1 more source

Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Objective(s):Long-term treatment with antipsychotics causes serious side effects such as tardive dyskinesia that characterized by abnormal movements in the orofacial region. Oxidative stress in the brain specific area is implicated in the pathophysiology
Marzyeh Kamyar   +5 more
doaj   +1 more source

Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia [PDF]

open access: yes, 2017
Background: Antipsychotic medication can cause tardive dyskinesia (TD) – late-onset, involuntary, repetitive movements, often involving the face and tongue. TD occurs in > 20% of adults taking antipsychotic medication (first-generation antipsychotics for
Adamd   +258 more
core   +3 more sources

Tardive dyskinesia: apropos of a case. This is a case related to drug side effects, whose uniqueness lies in the time of onset of symptoms, Tardive dyskinesia is a drug-induced hyperkinetic movement disorder.

open access: yesEuropean Psychiatry, 2023
Introduction Tardive dyskinesia is finally diagnosed, it is a drug-induced hyperkinetic movement disorder associated with the use of dopamine receptor blocking agents, including first and second generation antipsychotic drugs, metoclopramide and ...
R. F. Díaz
doaj   +1 more source

Home - About - Disclaimer - Privacy